Post-effective amendment to a registration statement that is not immediately effective upon filing

Consolidated Statements of Operations

v3.22.1
Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Apr. 03, 2022
Mar. 31, 2021
Jan. 02, 2022
Dec. 31, 2020
Operating expenses:        
Cost of revenue $ 515 $ 1,631 $ 1,967 $ 3,375
Research and development 12,731 5,589 37,850 14,442
Selling, general and administrative 11,869 4,161 29,705 5,713
Total operating expenses 25,115 11,381 69,522 23,530
Loss from operations (25,115) (11,381) (69,522) (23,530)
Other income (expense):        
Change in fair value of convertible preferred stock warrants and common stock warrants 67,800 (4,781) (56,141) (13,789)
Issuance of convertible preferred stock warrants     0 (1,476)
Change in fair value of convertible promissory notes     0 (2,422)
Gain on extinguishment of paycheck protection program loan     0 1,628
Interest expense, net     (187) (107)
Other income (expense), net 22 (3) (24) 46
Total other income (expense), net 67,822 (4,784) (56,352) (16,120)
Net income (loss) $ 42,707 $ (16,165) $ (125,874) $ (39,650)
Net income (loss) per share, basic $ 0.28 $ (0.17)    
Weighted average number of common shares outstanding, basic 151,648,439 95,816,889    
Net loss per share, diluted $ (0.16) $ (0.17)    
Weighted average number of common shares outstanding, diluted 153,338,462 95,816,889    
Net loss per share, basic and diluted     $ (1.07) $ (0.49)
Weighted average number of common shares outstanding, basic and diluted     117,218,893 80,367,324